Filing Details

Accession Number:
0000899243-20-034268
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-17 14:39:27
Reporting Period:
2020-12-16
Accepted Time:
2020-12-17 14:39:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1062822 Lexicon Pharmaceuticals Inc. LXRX Pharmaceutical Preparations (2834) 760474169
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1340096 Invus Public Equities Advisors, Llc 750 Lexington Avenue, 30Th Floor
New York NY 10022
Yes No Yes No
1340097 Invus Public Equities, L.p. 750 Lexington Avenue, 30Th Floor
New York NY 10022
Yes No Yes No
1404553 Invus Advisors, L.l.c. 750 Lexington Avenue, 30Th Floor
New York NY 10022
Yes No Yes No
1404570 Invus, L.p. 750 Lexington Avenue, 30Th Floor
New York NY 10022
Yes No Yes No
1766952 Ltd Treasury Artal Suite 4, Borough House, Rue Du Pre
St. Peter Port Y7 GY1 3JJ
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-16 10,937,500 $3.20 32,259,461 No 4 P Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnotes
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,516,214 Indirect See Footnotes
Common Stock 35,402,689 Indirect See Footnotes
Footnotes
  1. On December 11, 2020, Artal International S.C.A. entered into a subscription agreement with the Issuer and other parties thereto, pursuant to which Artal International S.C.A. agreed to purchase 10,937,500 shares of Class A common stock of the Issuer at a price of $3.20 per share. The purchase closed on December 16, 2020.
  2. These securities are directly held by Artal International S.C.A.
  3. These securities are directly held by Invus Public Equities, L.P.
  4. These securities are directly held by Invus, L.P.
  5. Invus Public Equities Advisors, LLC is the general partner of Invus Public Equities, L.P., and Invus Advisors, L.L.C. is the general partner of Invus, L.P. Artal Treasury Limited is the managing member of Invus Public Equities Advisors, LLC. Artal International S.C.A. is the managing member of Invus Advisors, L.L.C. and, through its Geneva branch, is the sole stockholder of Artal Treasury Limited. The managing partner of Artal International S.C.A. is Artal International Management S.A. The parent company of Artal International Management S.A. is Artal Group S.A. The parent company of Artal Group S.A. is Westend S.A. The majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend (the "Stichting"). Mr. Pascal Minne is the sole member of the board of the Stichting.
  6. Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
  7. Due to the limitations of the electronic filing system certain Reporting Persons are filing a separate Form 4.